Title 21

PART 250

Part 250 - Special Requirements For Specific Human Drugs

PART 250 - SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS Authority:21 U.S.C. 321, 336, 342, 352, 353, 355, 361(a), 362(a) and (c), 371, 375(b). Source:40 FR 14033, Mar. 27, 1975, unless otherwise noted.

21:4.0.1.1.16.1SUBPART A
Subpart A - Drugs Regarded as Misbranded
21:4.0.1.1.16.1.1.1SECTION 250.11
   250.11 Thyroid-containing drug preparations intended for treatment of obesity in humans.
21:4.0.1.1.16.1.1.2SECTION 250.12
   250.12 Stramonium preparations labeled with directions for use in self-medication regarded as misbranded.
21:4.0.1.1.16.2SUBPART B
Subpart B - New Drug or Prescription Status of Specific Drugs
21:4.0.1.1.16.2.1.1SECTION 250.100
   250.100 Amyl nitrite inhalant as a prescription drug for human use.
21:4.0.1.1.16.2.1.2SECTION 250.101
   250.101 Amphetamine and methamphetamine inhalers regarded as prescription drugs.
21:4.0.1.1.16.2.1.3SECTION 250.102
   250.102 Drug preparations intended for human use containing certain “coronary vasodilators”.
21:4.0.1.1.16.2.1.4SECTION 250.103-250.104
   250.103-250.104 [Reserved]
21:4.0.1.1.16.2.1.5SECTION 250.105
   250.105 Gelsemium-containing preparations regarded as prescription drugs.
21:4.0.1.1.16.2.1.6SECTION 250.106-250.107
   250.106-250.107 [Reserved]
21:4.0.1.1.16.2.1.7SECTION 250.108
   250.108 Potassium permanganate preparations as prescription drugs.
21:4.0.1.1.16.3SUBPART C
Subpart C - Requirements for Drugs and Foods
21:4.0.1.1.16.3.1.1SECTION 250.201
   250.201 Preparations for the treatment of pernicious anemia.
21:4.0.1.1.16.4SUBPART D
Subpart D - Requirements for Drugs and Cosmetics
21:4.0.1.1.16.4.1.1SECTION 250.250
   250.250 Hexachlorophene, as a component of drug and cosmetic products.